Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized, double blind study of MP-513 added to metformin in type 2 diabetes mellitus
KCT0000709Phase 3Active, not recruiting
- Sponsor
- Handok
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Handok. Started Jul 2012; status: active, not recruiting.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0000709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000709.